Company research / JANX
Janux Therapeutics, Inc. (JANX)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Janux Therapeutics, Inc. reported revenue of $10.00M. Revenue fell 5.6% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $24.00M.
Key ratios (year ended 2025-12-31)
n/m
Operating margin
n/m
Net margin
-11.9%
Return on year-end equity
-5.6%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.